Madrigal Pharmaceuticals Inc
$327.67
(as of Mar 28, 3:58 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Madrigal Pharmaceuticals Inc
Stock Price
$327.67
Ticker Symbol
MDGL
Exchange
NASDAQ
Industry Information for Madrigal Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Fundamentals for Madrigal Pharmaceuticals Inc
Market Capitalization
$7,239,435,264
EBITDA
$-496,779,008
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-21.90
Earnings per Share Estimate Next Year
Profit Margin
-258.64%
Shares Outstanding
22,080,200
Percent Owned by Insiders
8.75%
Percent Owned by Institutions
105.10%
52-Week High
52-Week Low
Technical Indicators for Madrigal Pharmaceuticals Inc
Analyst Ratings for Madrigal Pharmaceuticals Inc
Strong Buy
9
Buy
4
Hold
2
Sell
1
Strong Sell
0
News About Madrigal Pharmaceuticals Inc
Mar 28, 2025, 6:54 PM EST
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. See more.
Mar 28, 2025, 1:08 PM EST
In the last week, the United States market has stayed flat, but it is up 7.8% over the past year with earnings forecast to grow by 14% annually. See more.
Mar 18, 2025, 5:28 AM EST
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. See more.
Mar 11, 2025, 8:00 AM EST
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025
See more.